Journal ID (nlm-ta): Signal Transduct Target Ther
Journal ID (iso-abbrev): Signal Transduct Target Ther
Title:
Signal Transduction and Targeted Therapy
Publisher:
Nature Publishing Group UK
(London
)
ISSN
(Print):
2095-9907
ISSN
(Electronic):
2059-3635
Publication date
(Electronic):
20
October
2023
Publication date PMC-release: 20
October
2023
Publication date Collection: 2023
Volume: 8
Electronic Location Identifier: 400
Affiliations
[1
]Cancer Centre, Telethon Kids Institute, (
https://ror.org/01dbmzx78)
Nedlands, WA 6009 Australia
[2
]Centre For Child Health Research, University of Western Australia, (
https://ror.org/047272k79)
Perth, WA 6009 Australia
[3
]Immunology Division, The Walter and Eliza Hall Institute of Medical Research, (
https://ror.org/01b6kha49)
Melbourne, 3052 Australia
[4
]Department of Medical Biology, University of Melbourne, (
https://ror.org/01ej9dk98)
Melbourne, 3010 Australia
[5
]Personalised Oncology Division, The Walter and Eliza Hall Institute of Medical Research,
(
https://ror.org/01b6kha49)
Melbourne, 3052 Australia
[6
]School of Biomedical Sciences, University of New South Wales, (
https://ror.org/03r8z3t63)
Sydney, 2052 Australia
Author information
Article
Publisher ID:
1637
DOI: 10.1038/s41392-023-01637-8
PMC ID: 10587102
PubMed ID: 37857607
SO-VID: cef1946e-53d6-43bf-8d84-adabcb875749
Copyright © © West China Hospital, Sichuan University 2023
License:
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License,
which permits use, sharing, adaptation, distribution and reproduction in any medium
or format, as long as you give appropriate credit to the original author(s) and the
source, provide a link to the Creative Commons license, and indicate if changes were
made. The images or other third party material in this article are included in the
article’s Creative Commons license, unless indicated otherwise in a credit line to
the material. If material is not included in the article’s Creative Commons license
and your intended use is not permitted by statutory regulation or exceeds the permitted
use, you will need to obtain permission directly from the copyright holder. To view
a copy of this license, visit
http://creativecommons.org/licenses/by/4.0/.
Funded by: FundRef https://doi.org/10.13039/100008018, Victorian Cancer Agency (VCA);
Award ID: MCRF22003
Award Recipient
:
Sarah A. Best
Funded by: FundRef https://doi.org/10.13039/501100000925, Department of Health | National Health and Medical Research Council (NHMRC);
Award ID: GNT1184421
Award Recipient
:
Saskia Freytag
Funded by: Prof Johns is also supported by the Perth Children’s Hospital Foundation (9896) and
a WA Child Research Fund grant
Funded by: FundRef https://doi.org/10.13039/501100001170, Cancer Council Western Australia;
Funded by: The Pirate Ship Foundation, Brainchild Fellowship